← Back to Search

Ketone Ester

Ketone Ester for Cardiovascular Disease

N/A

Waitlist Available

Led By Gregory J Grosicki, PhD

Research Sponsored by Georgia Southern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up night one of supplement ingestion (i.e., from time asleep to time awake for one night per condition)

Awards & highlights

Study Summary

This trial is studying whether ketone supplements can reduce blood pressure & improve heart health in older adults.

Eligible Conditions

Cardiovascular Disease
Sleep
Aging

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ pre-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~pre-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and pre-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Nocturnal blood pressure dipping

Secondary outcome measures

Nighttime blood pressure

Nighttime heart rate variability

Objective sleep duration

+4 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Ketone EsterExperimental Treatment1 Intervention

Participants will consume the supplement prior to bedtime. Nocturnal blood pressure, heart rate, and sleep characteristics will be assessed

Group II: Placebo SupplementPlacebo Group1 Intervention

Participants will consume the supplement prior to bedtime. Nocturnal blood pressure, heart rate, and sleep characteristics will be assessed

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Ketone Ester

2023

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Auburn UniversityOTHER

72 Previous Clinical Trials

14,365 Total Patients Enrolled

Georgia Southern UniversityLead Sponsor

7 Previous Clinical Trials

2,465 Total Patients Enrolled

Gregory J Grosicki, PhDPrincipal InvestigatorGeorgia Southern University

Media Library

Ketone Ester Supplementation (Ketone Ester) Clinical Trial Eligibility Overview. Trial Name: NCT05888506 — N/A

Cardiovascular Disease Research Study Groups: Placebo Supplement, Ketone Ester

Cardiovascular Disease Clinical Trial 2023: Ketone Ester Supplementation Highlights & Side Effects. Trial Name: NCT05888506 — N/A

Ketone Ester Supplementation (Ketone Ester) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05888506 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants currently being enrolled into this experiment?

"According to information posted on clinicaltrials.gov, the initial posting of this trial was June 1st 2023 and it has not been seeking participants since May 31st 2023. Nevertheless, there are 827 other studies that are actively recruiting right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ketone Ester Supplementation and Nocturnal Blood Pressure

2023. "Ketone Ester Supplementation and Nocturnal Blood Pressure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05888506.